Top

Gepubliceerd in:

01-04-2014

Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes

Auteurs: Abigail W. Batchelder, Jeffrey S. Gonzalez, Karina M. Berg

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 2/2014

Abstract

Increased antiretroviral availability has decreased mortality and increased rates of comorbid chronic illnesses, including type 2 diabetes, among people living with HIV. Little work has compared within-person adherence rates for HIV and comorbid conditions. Sixty-two adults with HIV and type 2 diabetes reported adherence rates, illness representations, beliefs about medications, symptoms, side-effects, and negative mood states. Adherence to antiretrovirals was better than diabetes medication (95 vs. 90 %, z = −2.05, p = 0.04). Participants reported better control over diabetes compared to HIV (t = 1.98, p = 0.05) while antiretrovirals were considered more necessary than diabetes medication (t = −2.79, p < 0.05). In adjusted analyses, antiretroviral nonadherence was associated with antiretroviral concerns (OR = 0.24, 95 % CI 0.08–0.67) and diabetes medication nonadherence with diabetes-related symptom burden (OR = 0.69, 95 % CI 0.53–0.89). Results indicate that medication nonadherence varies within individuals across comorbid illnesses and suggest this variation may depend on symptom attribution and medication concerns.

vorige artikel Learning about pain through observation: the role of pain-related fear

volgende artikel Self-disclosure of serostatus by youth who are HIV-positive: a review

Amico, K. R., Fisher, W. A., Cornman, D. H., Shuper, P. A., Redding, C. G., Konkle-Parker, D. J., et al. (2006). Visual analog scale of ART adherence: Association with 3-day self-report and adherence barriers. Journal of Acquired Immune Deficiency Syndrome, 42, 455–459.CrossRef

Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., et al. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445–449.PubMedCrossRef

Anderson, G. (2010). Chronic care: Making the case for ongoing care. Princeton, NJ: Robert Woods Johnson Foundation.

Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.PubMedCrossRef

Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., et al. (1998). The women’s interagency HIV study. WIHS collaborative study group. Epidemiology, 9, 117–125.PubMedCrossRef

Berg, K. M., Wilsin, I. B., Li, X., & Arnsten, J. H. (2012). Comparison of antiretroviral adherence questions. AIDS and Behavior, 16, 461–468.PubMedCentralPubMedCrossRef

Bower, P., Harkness, E., Macdonald, W., Coventry, P., Bundy, C., & Moss-Morris, R. (2012). Illness representations in patients with multimorbid long-term conditions: Qualitative study. Psychology and Health, 1, 1–16.

Brown, T. T., Cole, S. R., Li, X., Kingsley, L. A., Palella, F. J., Riddler, S. A., et al. (2005). Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 165, 1179–1184.PubMedCrossRef

Brown, C. S., Wright, R. G., & Christensen, D. B. (1987). Association between type of medication instruction and patients’ knowledge, side effects, and compliance. Hospital & Community Psychiatry, 38, 55–60.

Burgess, A., Dayer, M., Catalan, J., Hawkins, D., & Gazzard, B. (1993). The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis. AIDS, 7, 1001–1008.PubMedCrossRef

Butt, A. A., McGinnis, K., Rodriguez-Barradas, M. C., Crystal, S., Simberkoff, M., Goetz, M. B., et al. (2009). HIV infection and the risk of diabetes mellitus. AIDS, 23, 1227–1234.PubMedCentralPubMedCrossRef

Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999). Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet, 353, 2093–2099.PubMedCrossRef

Center for Disease Control and Prevention. (2012). HIV in the United States: At a glance. Retrieved from http://www.cdc.gov/hiv/resources/factsheets/us.htm

Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, S271–S278.PubMedCrossRef

Cooper, V., Gellaitry, G., Hankins, M., & Fisher, M. (2009). The influence of symptom experiences and attributions on adherence to highly active antiretroviral therapy (HAART): A six-month prospective, follow-up study. AIDS Care—Psychological and Socio-Medical Aspects of AIDS/HIV, 21, 520–528.CrossRef

de Groot, M., Pinkerman, B., Wagner, J., & Hockman, E. (2006). Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care, 29, 549–553.PubMedCrossRef

Detweiler-Bedell, J. B., Friedman, M. A., Leventhal, H., Miller, I. W., & Leventhal, E. A. (2008). Integrating co-morbid depression and chronic physical disease management: Identifying and resolving failures in self-regulation. Clinical Psychology Review, 28, 1426–1446.PubMedCentralPubMedCrossRef

Fisher, L., Mullan, J. T., Arean, P., Glasgow, R. E., Hessler, D., & Masharani, U. (2010). Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care, 33, 23–28.PubMedCentralPubMedCrossRef

Fisher, L., Skaff, M. M., Mullan, J. T., Arean, P., Mohr, D., Masharani, U., et al. (2007). Clinical depression versus distress among patients with type 2 diabetes: Not just a question of semantics. Diabetes Care, 30, 542–548.PubMedCrossRef

Garcia de Olalla, P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105–110.PubMedCrossRef

Giordano, T. P., Gifford, A. L., White, A. C., Jr, Suarez-Almazor, M. E., Rabeneck, L., Hartman, C., et al. (2007). Retention in care: A challenge to survival with HIV infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44, 1493–1499.CrossRef

Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011a). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58, 181–187.PubMed

Gonzalez, J. S., Fisher, L., & Polonsky, W. H. (2011b). Depression in diabetes: Have we been missing something important? Diabetes Care, 34, 236–239.PubMedCentralPubMedCrossRef

Gonzalez, J. S., Penedo, F. J., Llabre, M. M., Duran, R. E., Antoni, M. H., Schneiderman, N., et al. (2007). Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine, 34, 46–55.CrossRef

Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., et al. (2008). Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care, 31, 2398–2403.PubMedCentralPubMedCrossRef

Gonzalez, J. S., & Schneider, H. (2011). Methodological issues in the assessment of diabetes treatment adherence. Current Diabetes Reports, 11, 472–479.PubMedCrossRef

Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., et al. (2006). Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine, 166, 1836–1841.PubMedCrossRef

Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS, 15, 38–44.PubMedCrossRef

Horne, R., Cooper, V., Gellaitry, G., Date, H. L., & Fisher, M. (2007). Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndromes, 45, 334–341.PubMed

Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555–567.PubMedCrossRef

Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14, 1–24.CrossRef

Kalichiman, S. C., et al. (2009). A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care, 8, 367–374.CrossRef

Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: Development of a pictographic visual analogue scale. Health Education Research, 20, 24–35.PubMedCrossRef

Kalichman, S. C., Rompa, D., & Cage, M. (2000). Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. The Journal of Nervous and Mental Disease, 188, 662–670.PubMedCrossRef

Lau, R. R., Bernard, T. M., & Hartman, K. A. (1989). Further explorations of common-sense representations of common illnesses. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 8, 195–219.CrossRef

Leventhal, H. (1990). Emotional and behavioral processes. In M. Jacobson & L. Wallace (Eds.), Stress and medical procedures (pp. 25–57). Oxford, England: Oxford University Press.

Leventhal, H., Diefenbach, M., & Leventhal, E. A. (1992). Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research, 16, 143–163.CrossRef

Leventhal, H., Leventhal, E. A., & Contrada, R. J. (1998). Self-regulation, health, and behavior: A perceptual-cognitive approach. Psychology and Health, 13, 717–733.CrossRef

Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense model of illness danger. In S. Rachman (Ed.), Medical psychology (pp. 7–30). New York, NY: Pergamon.

Leventhal, H., Nerenz, D. R., & Steele, D. J. (1984). Illness representations and coping with health threats. In A. Baum, S. E. Taylor, & J. E. Singer (Eds.), Handbook of psychology and health: Social psychological aspects of health (pp. 219–252). Hillsdale, NJ: Earlbaum.

Leyva, B., Zagarins, S. E., Allen, N. A., & Welch, G. (2011). The relative impact of diabetes distress vs depression on glycemic control in hispanic patients following a diabetes self-management education intervention. Ethnicity and Disease, 21, 322–327.PubMed

Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360–361.PubMedCrossRef

Moss-Morris, R., Weinman, J., Petrie, K. J., Horne, R., Cameron, L. D., & Buick, D. (2002). The revised illness perception questionnaire (IPQ-R). Psychology and Health, 17, 1–16.CrossRef

Neuhaus, J., Angus, B., Kowalska, J. D., La Rosa, A., Sampson, J., Wentworth, D., et al. (2010). Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS, 24, 697–706.PubMedCentralPubMedCrossRef

Paik, I. J. (2011). The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 469–479.CrossRef

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedCrossRef

Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., et al. (2005). Assessing psychosocial distress in diabetes: Development of the diabetes distress scale. Diabetes Care, 28, 626–631.PubMedCrossRef

Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measures, 1, 386–401.CrossRef

Sackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006). Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Annals of Internal Medicine, 145, 397–406.PubMedCrossRef

Schuz, B., Wurm, S., Warner, L. A., & Ziegelmann, J. P. (2012). Self-efficacy and multiple illness representations in older adults: A multilevel approach. Psychology & Health, 27, 13–29.CrossRef

Searle, A., Norman, P., Thompson, R., & Vedhara, K. (2007). Illness representations among patients with type 2 diabetes and their partners: Relationships with self-management behaviors. Journal of Psychosomatic Research, 63, 175–184.PubMedCrossRef

Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245.PubMedCrossRef

Spollett, G. R. (2006). From research to practice/glycemic challenges: Hyperglycemia and HIV/AIDS. Diabetes Spectrum, 19, 163–166.CrossRef

Stutterheim, S. E., Pryor, J. B., Bos, A. E., Hoogendijk, R., Muris, P., & Schaalma, H. P. (2009). HIV-related stigma and psychological distress: The harmful effects of specific stigma manifestations in various social settings. AIDS, 23, 2353–2357.PubMedCrossRef

Taiwo, B. O. (2005). Insulin resistance, HIV infection, and anti-HIV therapies. The AIDS Reader, 15, 171–180.PubMed

van Bastelaar, K. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Tack, C. J., Bazelmans, E., Beekman, A. T., et al. (2010). Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in type 1 and type 2 diabetes. Diabetic Medicine: A Journal of the British Diabetic Association, 27, 798–803.CrossRef

Vance, D. E., Mugavero, M., Willig, J., Raper, J. L., & Saag, M. S. (2011). Aging with HIV: A cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. The Journal of the Association of Nurses in AIDS Care, 22, 17–25.PubMedCrossRef

Volberding, P. A. (2003). HIV therapy in 2003: Consensus and controversy. AIDS, 17, S4–S11.PubMedCrossRef

Weinman, J., Petrie, K., Moss-Morris, R., & Horne, R. (1996). The illness perception questionnaire: A new method for assessing the cognitive representation of illness. Psychology and Health, 11, 431–445.CrossRef

Weiss, J. J., Antoni, M. H., Mulder, C. L., & Garssen, B. (1998). Attitudes and age are related to adherence to combination therapy in HIV-1 positive gay men. Geneva, Switzerland: Proceedings from International Conference of AIDS.

Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 6, 481–493.CrossRef

Titel: Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes
Auteurs: Abigail W. Batchelder
Jeffrey S. Gonzalez
Karina M. Berg
Publicatiedatum: 01-04-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 2/2014
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-012-9486-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2014

Improving secondary stroke self-care among underserved ethnic minority individuals: a randomized clinical trial of a pilot intervention

Comparative optimism among patients with coronary heart disease (CHD) is associated with fewer adverse clinical events 12 months later

Self-disclosure of serostatus by youth who are HIV-positive: a review

Learning about pain through observation: the role of pain-related fear

Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT)

A self-regulation lifestyle program for post-cardiac rehabilitation patients has long-term effects on exercise adherence